ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

COCP Cocrystal Pharma Inc

1.59
0.06 (3.92%)
시간외 거래
최종 업데이트: 05:10:01
15분 지연
기업명 주식 심볼 시장 주식 타입
Cocrystal Pharma Inc COCP 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.06 3.92% 1.59 05:10:01
개장가 저가 고가 종가 전일 종가
1.53 1.52 1.59 1.59 1.53
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202421:00GLOBEEnrollment Completed in Phase 2a Study with Cocrystal..
28/03/202421:00GLOBECocrystal Pharma Reports 2023 Financial Results and Provides..
19/03/202421:00GLOBECocrystal Pharma Receives Pre-IND Responses from the FDA on..
02/03/202406:15EDGAR2Form 8-K - Current report
08/01/202422:00EDGAR2Form 8-K - Current report
05/01/202406:01EDGAR2Form 8-K - Current report
04/01/202422:00GLOBECocrystal Pharma Provides an Update on the Clinical..
02/01/202423:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/12/202307:00EDGAR2Form 8-K - Current report
06/12/202322:00EDGAR2Form 8-K - Current report
06/12/202322:00GLOBECocrystal Pharma Announces First-Patient-In for Phase 2a..
04/12/202322:00EDGAR2Form 8-K - Current report
29/11/202322:00EDGAR2Form 8-K - Current report
29/11/202322:00GLOBECocrystal Pharma Highlights its Novel Inhaled and Oral..
27/11/202322:00GLOBECocrystal Pharma to Present at the NobleCon 19 Conference on..
13/11/202322:15EDGAR2Form 8-K - Current report
13/11/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:00GLOBECocrystal Pharma Reports Third Quarter 2023 Financial..
09/11/202322:00GLOBECocrystal Pharma to Discuss Progress with Novel Inhaled and..
31/10/202321:00EDGAR2Form 8-K - Current report
31/10/202321:00GLOBECocrystal Pharma Receives UK MHRA Authorization to Initiate..
28/09/202321:00GLOBECocrystal Pharma Doses First Subjects in Clinical Study of..
05/09/202321:00GLOBECocrystal Pharma to Participate in the H.C. Wainwright..
17/08/202305:05EDGAR2Form 8-K - Current report
14/08/202321:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/08/202321:00GLOBECocrystal Pharma Reports Second Quarter 2023 Financial..
08/08/202321:00GLOBECocrystal Pharma Selects Novel Oral Protease Inhibitor..
21/07/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/07/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/07/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/07/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/05/202321:00GLOBECocrystal Pharma Receives HREC Approval to Initiate Phase 1..
15/05/202321:00GLOBECocrystal Pharma Reports First Quarter 2023 Financial..
05/05/202305:05GLOBECocrystal Pharma Presents New Data from its CC-42344 Phase 1..

최근 히스토리

Delayed Upgrade Clock